Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.
- SUBJECT label "dexamethasone , a widely available and inexpensive corticosteroid with anti-inflammatory effects ," provenance.